Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Subject : drug efficacy

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

تأثیر آهن زدایی با دفرازیروکس بر سطح آنزیمهای کبدی بیماران B- تالاسمی وابسته به تزریق خون.

Authors : شایان پورکاظم¹; محمدرضا شریفی را¹; عادل باقر سلیمی¹

Source: Journal of Guilan University of Medical Sciences. Summer2024, Vol. 33 Issue 2, p202-215. 14p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dose of deferasirox correlates with its effects, which differ between low‐risk myelodysplastic syndrome and aplastic anaemia.

Authors : Zhang, Ruoxi¹; Han, Bing¹

Source: Journal of Clinical Pharmacy & Therapeutics. Oct2022, Vol. 47 Issue 10, p1619-1626. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Authors : Maurillo, Luca¹; Breccia, Massimo²; Buccisano, Francesco^1,3

Source: European Journal of Haematology. Jul2015, Vol. 95 Issue 1, p52-56. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond ( GIMEMA MDS0306 Trial).

Authors : Angelucci, Emanuele¹; Santini, Valeria²; Tucci, Anna Angela¹

Source: European Journal of Haematology. Jun2014, Vol. 92 Issue 6, p527-536. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox Versus Deferoxiamine for the Treatment of Transfusional Iron Overload in Patients with β-Thalassemia Major.

Authors : Ibrahiem, Osama A.¹ ; Thabet, Ahmad F.¹

Source: Ibnosina Journal of Medicine & Biomedical Sciences. 2014, Vol. 6 Issue 1, p14-18. 5p. 2 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy and safety of Iranian made Deferasirox (Osveral) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study.

Authors : Eshghi, R.¹ ; Farahmandinia, Z.²; Molavi, M.³

Source: DARU: Journal of Pharmaceutical Sciences. Summer2011, Vol. 19 Issue 3, p240-248. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major.

Authors : Chandra, J (AUTHOR) ; Chaudhary, H (AUTHOR); Pemde, H (AUTHOR)

Source: Annals of Tropical Paediatrics. Feb2011, Vol. 31 Issue 1, p47-51. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload.

Authors : Aydinok, Yesim¹; Unal, Sule²; Oymak, Yesim³

Source: European Journal of Haematology. May2012, Vol. 88 Issue 5, p431-438. 8p. 4 Charts, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.

Authors : Elalfy, Mohsen S.¹; Adly, Amira M¹; Wali, Yasser²

Source: European Journal of Haematology. Nov2015, Vol. 95 Issue 5, p411-420. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Influence of single-nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness.

Authors : Cusato, J¹; Allegra, S¹; Massano, D²

Source: Pharmacogenomics Journal. Jun2015, Vol. 15 Issue 3, p263-271. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

تأثیر آهن زدایی با دفرازیروکس بر سطح آنزیمهای کبدی بیماران B- تالاسمی وابسته به تزریق خون.

Dose of deferasirox correlates with its effects, which differ between low‐risk myelodysplastic syndrome and aplastic anaemia.

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond ( GIMEMA MDS0306 Trial).

Deferasirox Versus Deferoxiamine for the Treatment of Transfusional Iron Overload in Patients with β-Thalassemia Major.

Efficacy and safety of Iranian made Deferasirox (Osveral) in Iranian major thalassemic patients with transfusional iron overload: A one year prospective multicentric open-label non-comparative study.

Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major.

Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload.

Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.

Influence of single-nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness.

اتصل بنا

اتبع